Table 1.
Characteristics of the study participants (total number = 79).
| Variable | Number (No) | Percent (%) |
|---|---|---|
| Age (Years) | ||
| 18–24 | 9 | 11.39 % |
| 25–29 | 15 | 18.98 % |
| 30–34 | 18 | 22.78 % |
| 35–39 | 13 | 16.45 % |
| 40–45 | 24 | 30.37 % |
| History of COVID-19 infection | ||
| Yes | 31 | 39.24 % |
| No | 48 | 60.76 % |
| Menstruation pattern before COVID-19 infection: | ||
| Regular cycle | 26 | 83.87 % |
| Irregular cycle | 5 | 16.13 % |
| Menstruation pattern after COVID-19 infection: | ||
| Regular cycle | 8 | 25.81 % |
| Irregular cycle | 23 | 74.19 % |
| Types of received doses of COVID-19 vaccine: | ||
| First dose: | ||
| Pfizer | 62 | 78.48 % |
| AstraZeneca | 9 | 11.39 % |
| Moderna | 8 | 10.12 % |
| Second dose: | ||
| Pfizer | 70 | 92.11 % |
| AstraZeneca | 3 | 3.94 % |
| Moderna | 3 | 3.94 % |
| Third dose: | ||
| Pfizer | 46 | 93.88 % |
| AstraZeneca | 0 | 0 % |
| Moderna | 3 | 6.12 % |
| Menstruation pattern before COVID-19 vaccine: | ||
| Regular cycle | 66 | 83.54 % |
| Irregular cycle | 13 | 16.46 % |
| Menstruation pattern after COVID-19 vaccine: | ||
| Regular cycle | 22 | 27.85 % |
| Irregular cycle | 57 | 72.15 % |